Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice
High levels of aldosterone are associated with vascular and cardiac remodeling, myocardial fibrosis, and endothelial dysfunction with consequent increased risk of cardiovascular events and cardiovascular mortality. Indeed, mineralcorticoid receptor antagonists (MRAs) are recommended in the treatment...
Saved in:
| Main Authors: | Maria Alfarano, MD, PhD, Giulia Marchionni, MD, Jacopo Costantino, MD, Federico Ballatore, MD, Romina Verardo, PhD, Fabio Miraldi, MD, Francesco Luigi Ciciarello, MD, Luigi Petramala, MD, Claudio Letizia, MD, Andrea Frustaci, MD, Cristina Chimenti, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | JACC: Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772963X25001796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
by: Houry Puzantian, et al.
Published: (2024-12-01) -
Usefulness of Intracardiac Echocardiography-Guided Endomyocardial Biopsy for Diagnosing Transthyretin Cardiac Amyloidosis During Catheter AblationNovel Teaching Points
by: Maoko Atsumi, MD, et al.
Published: (2025-08-01) -
Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01) -
Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonists in primary aldosteronism
by: Sittikul Thipbumrung, et al.
Published: (2025-07-01) -
Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantation
by: Leendert C. Kieviet, BsC, et al.
Published: (2025-08-01)